The move by the agency will authorize the sale of product in the Canadian market.
Omazen is EPA:DHA fatty acid formulation, which elevates Omega-3 fatty acid levels and helps maintain good health.
According to the Natural Health Products Directorate (NHPD), Omazen is compliant with Natural Health Products Regulations.
Pivotal Therapeutics chair and chief scientific officer George Jackowski said their Omega-3 formulation is different as proven by the clinical data.
"As consumers increase their awareness of interpreting product label information they will realize the superiority of Omazen," Jackowski added.